Pandora Report 1.29.2016

Happy Friday! Now that winter storm Jonas is behind us, we can get back to tackling biodefense updates. Unless you’ve been avoiding the news, you’ve undoubtedly seen the surge in reports on Zika virus. Imported cases are popping up throughout the US, raising concerns about vulnerability and response. We’ll be covering the latest in Zika news, not to mention a pretty amazing disease modeling system, plague history, and how Brazil is prepping for the 2016 Olympics. Fun History Fact Friday: on January 28th, 2000, a US government study finally conceded that the cancer and premature deaths of several workers from a nuclear weapons plant (in service since WWII) were caused by radiation and chemicals and sticking with the nuclear weapon theme, on January 29th, 1964, Dr. Strangelove or: How I Learned to Stop Worrying and Love the Atomic Bomb premiered.

Open Source Disease Modeling: to Combat the Next Pandemic
GMU Biodefense PhD student, Nereyda Sevilla, has teamed up with Global Biodefense to discuss how transportation advances of the 21st century make outbreak preparedness and response extremely difficult. In most cases, health alerts and travel restrictions are reactionary to an outbreak that has already reached epic proportions. In response to this, scientists are working to predict disease spread and potential interventions through disease modeling. Spatiotemporal Epidemiological Modeler (STEM)  is one of these modeling systems that looks at several variables and parameters within the spread of an infectious disease and then models the efficacy of interventions. “The unique nature of STEM is that it is a multi-disciplinary, collaborative modeling platform.  The open-source characteristics of the system allow researchers and programmers to add, compare, refine, and validate different scenarios as well as add denominator data based on specialty.  For example, an infectious disease specialist in dengue working in South America may have unique disease characteristics and population data that could be tailored into STEM.” The best part? STEM is already pre-loaded with country data regarding national borders, transportation networks, air travel, and environmental conditions. Utilizing customized graphs and spatial maps, it can even be used to “create a spatial map of animal pens on a farm and to import that graph into the model to study the spread of a veterinary disease.” STEM can easily be downloaded and even has sample projects that many researchers from around the world have shared, like the 2014 Ebola outbreak, dengue fever, H1N1, etc. STEM is undoubtedly a significant weapon in the global health security arsenal to combat future pandemics.

Zika Virus Outbreak Updates
While 200,000 Brazilian troops are being mobilized to battle mosquitoes in a house-to-house strategy, Zika virus has reached 23 countries. As of January 28th, 2016, the WHO has set up an emergency team to respond to the growing epidemic. Meeting on Monday, the WHO team will decide if the Zika virus outbreak should be treated as a global emergency, as they are predicting “three to four million cases” in the Americas. Fear continues to grow in the US as cases are popping up in Los Angeles Country, CA Virginia, New York, and Arkansas, in a returned travelers. President Obama just called for a speeding up of Zika virus research to battle the growing outbreak. Sydney has also confirmed imported cases. While many worry that returning travelers are bringing the mosquito-borne disease back home, it’s important to note that it’s during the first week of infection that the virus is found in the blood and can be transmitted via mosquitoes.  Vertical transmission (from mother to child) is possible if the maternal infection is near the time of delivery, but there haven’t been cases of Zika virus in breast milk. To date, there has been one case of transmission through blood transfusions and one possibly spread through semen and sexual contact. Researchers are working to piece together the origins of this particular outbreak, but one hypothesis is that it came to Brazil from a major sporting event, specifically the 2014 World Cup. At this point, cases have been seen in 23 countries and the WHO has warned that it’s likely to “spread across nearly all of the Americas”. While no local transmission has occurred in the US, locally acquired cases are occurring in the Commonwealth of Puerto Rico. The CDC has also released interim guidance on the evaluation and testing of infants with possible congenital Zika virus.

Brazil’s Olympic Woes

Courtesy of The Guardian & EPA
Courtesy of The Guardian & EPA

The growing outbreak of Zika virus and subsequent concerns over fetal microcephaly are just another public health issue on the laundry list of concerns for Brazil in their Olympic preparations. Building the infrastructure to support such a massive event is taxing on even the most industrialized country. Despite Brazil’s initial dismissal of water quality issues, there have been flourishing concerns over water safety for Olympians (the linked BBC pictures alone would have me rowing the boat back to land at record speed). 13 of the 40-member US rowing team experienced gastroenteritis after a trial run in a lake. While the exact culprit of the GI illness was never identified, it amplified the already increasing fears regarding water quality. It’s never a good sign when rowers are warned not to splash water or jump in at the end of a race, or when a sailor has to be hospitalized due to a severe MRSA infection after field tests. As we mentioned a few months back, an Associated Press investigation found dangerous viral and bacterial levels in the Olympic and Paralympic water venues. “Extreme water pollution is common in Brazil, where the majority of sewage is not treated. Raw waste runs through open-air ditches to streams and rivers that feed the Olympic water sites. As a result, Olympic athletes are almost certain to come into contact with disease-causing viruses that in some tests measured up to 1.7m times the level of what would be considered hazardous on a Southern California beach.” Water issues aside, vector-borne diseases like Zika virus, dengue, malaria, and even yellow fever, can pose a threat to those attending and participating in the events. The Brazilian health ministry has announced response plans in wake of the growing Zika virus outbreak. These large-scale events also raise security concerns, especially after the Paris attacks. Brazilian officials have promised “to guarantee absolute peace”  during the Olympics.

Congrats to 2015 GMU Biodefense MS alum, Francisco Cruz, on his acceptance as a fellow in UPMC’s 2016 Class of Emerging Leaders in Biosecurity Initiative (ELBI) The UPMC ELBI is a highly selective program that brings together and fosters partnerships within the biosecurity field. Biodefense MS alum, Francisco Cruz, will accompany several other prominent members of the biosecurity community in meetings, conferences, and networking. Congrats Francisco!

DNA Investigations from the Great Plague of Marseille
Always a sucker for a mixture of history and epidemiology, I was excited to come across this archaeological gem. Despite its initial devastation in the fourteenth century, the bubonic plague resurged and hit Europe with another destructive wave, “leading to continued high mortality and social unrest over the next three centuries.” Considered to be the last outbreak of medieval plague in Europe, the Great Plague of Marseille (1720-1722) has provided archaeologists with samples that allowed them to reconstruct the complete pathogen genome. Harnessing DNA from the teeth of victims within the Marseille plague pits, their results point to the disease hiding within the shadows of Europe for hundreds of years. Computational analyst Alexander Herbig notes, “we faced a significant challenge in reconstructing these ancient genomes. To our surprise, the 18th century plague seems to be a form that is no longer circulating, and it descends directly from the disease that entered Europe during the Black Death, several centuries earlier”. While they continue their work on tracing the origins of the disease and its mysterious disappearance, I’m hopeful that archaeogenetics is the new inspiration for future Indiana Jones films…

Stories You May Have Missed: 

  • Listeria Outbreak Associated With Dole Salads- A Dole production plan in Springfield, OH, is being linked to an outbreak of Listeria throughout the US and Canada. Twelve cases were identified in the US and another seven were found across five provinces in Canada. All twelve cases involved hospitalization and there has been one associated death. The CDC is continuing updates here.
  • USDA Updates on Highly Pathogenic Avian Influenza Fall Plan- The USDA has updated their plans to combat the highly pathogenic avian influenza with more details regarding reimbursement on virus elimination activities and additional information on the August 2015 industry survey on preparedness.
  • British Government and Bill & Melinda Gates Foundation Roll Out New Plan to Combat Malaria –  The British government has teamed up with the Bill and Melinda Gates Foundation to pledge three billion pounds to help stop malaria in the next fifteen years. Bill Gates and British Chancellor George Osborne stated, “We both believe that a malaria-free world has to be one of the highest global health priorities.” Britain will invest 500 million pounds a year over the next five years and the Bill and Melinda Gates Foundation have put up $200 million this year and will continue with annual donations.
  • Tales from the Front Lines in the Ebola Fight-  Confusion, disorganization, fear, and communication gaps fill the notes from the ground in this interview with VICE correspondent, Danny Gold, during his time in West Africa during the outbreak.

Enjoying your weekly dose of the Pandora Report? Sign up to receive it every week so the fun never ends! 

Pandora Report: 12.18.2015

Hungry, hungry anthrax hippos? If there’s one thing we love about the science community, it’s when a gem pops up in your inbox like this (thanks ProMed!). In Ebola news, public health officials are exploring the possibility that survivors may be a potential source of case surges. Fun history fact Friday: On December 18, 1620, the Mayflower docked at Plymouth Harbor and passengers began settlement and on December 14, 1980, the CIA issued a warning about Soviet arms sales to Third World nations. Take a break from holiday preparations with this week’s Pandora Report – we’re discussing everything from zombies to Bob Dylan lyrics!

Epidemiology of a Zombie Outbreak
Tara C Smith and the writers of The BMJ certainly know how to hook a biodefense nerd – epidemiology of zombie infections? Don’t mind if we do! Using historical tales and movie outbreaks, Smith takes us through several hypothetical zombie outbreaks we’ve experienced as viewers or readers for the past few decades. Tracing the origins of certain outbreaks and the transmission patterns via bite, this scientific approach to one of our favorite topics is fascinating.  Potential etiological considerations included weaponized Yersinia pestis, a mutation of bovine spongiform encephalopathy, or a genetically modified form of the Ebola virus that was tested on chimpanzees (that later escaped!). Last but not least, we can’t forget to consider the ethical implications of such an outbreak. How do we handle resource depletion or quarantine? All things to consider before the zombie apocalypse!

Risk & Benefit Analysis of Gain of Function Research 
With the National Science Advisory Board for Biosecurity (NSABB) meeting fast approaching (January 7-8, 2016!), we’re recapping the role of gain-of-function (GoF) research in biodefense. Earlier this year, Gryphon Scientific was awarded a NIH contract related to assessment of GoF research and the risk-versus-benefits that may impact future federal funding. With the intent to make future recommendations, the assessment had three major tasks: a risk analysis (RA) of accidents and natural disasters, a biosecurity RA, and a benefit assessment. Extensive review and analysis of data from the intelligence and law enforcement community reviewed potential gaps within security practices. “The biosecurity RA is delivered in two parts because risks posed by malicious acts targeting laboratories that conduct GoF required a different analytical approach than the assessment of the risk generated by the misuse of published GoF research.” GMU Biodefense alum and previous Pandora Report editor, Julia Homstad, is also the lead author on Chapter 11 (Risk of Loss of Trust in Science). Perhaps one of my favorite points from the report was that “this assessment requires the identification of scientific and non-scientific barriers to the realization of these benefits.” You can also find Michael Selgelid’s White Paper regarding the ethical implications of GoF research. While the 1,001 pages may seem a daunting task, this is not only a highly relevant report, but approaches GoF concerns and risks in an engaging and holistic manner.

Bob Dylan Lyrics in Medical Literature?
Have you ever read a scientific article and felt a complete unknown, like a rolling stone? Scientists at the Karolinska Institute in Sweden have been sneaking Bob Dylan song lyrics into their papers as part of a long-standing bet since 1997. “It all started in 1997 with a review in Nature Medicine entitled ‘Nitric oxide and inflammation: the answer is blowing in the wind.'” Carl Gornitzki and colleagues from The BMJ decided to do some additional digging in Medline and found that 213 of 727 found references were unequivocally citing Bob Dylan. Starting a few years after his musical debut, research papers included a variety of biomedical topics, like those of Hermanson et al., who managed to work “like a rolling stone” into their paper on epigenetics. The variety of lyrics found throughout the literature is certainly more than a simple twist of fate.

Outbreak Preparedness 2015 Report
Ever wonder how your state ranks in terms of emerging infectious disease preparedness? Trust for America’s Health and the Robert Wood Johnson Foundation recently published their 2015 report regarding state capabilities to protect against new infectious disease threats (MERS-CoV, multi-drug resistant organisms, etc.) and “resurging illnesses like whooping cough, tuberculosis, and gonorrhea.” The report found that over half of US states ranked at five or lower on a scale of ten. The five all-star states (scoring eight) were Delaware, Kentucky, Main, New York, and Virginia (go Virigina!). The report findings noted that “the nation must redouble efforts to protect Americans” and included points on healthcare-associated infections, flu vaccination rates, food safety, and superbugs. Check out the report to find where your state ranked!

Fighting Antibiotic Resistance in the United States18170_lores
On Thursday, the House Appropriations Committee presented the 2016 Omnibus Appropriations bill, which revealed discretionary funding plans for the federal government. Buried in new legislation, the FDA and NIH will receive part of this discretionary funding to help fight antibiotic resistant bacteria and “advance prevision medicine initiatives”. The FDA is set to receive $2.7 billion, which was over a $10 million increase from FY2015. Within the bill, there is “funding for the Combating Antibiotic Resistance Bacteria (CARB) initiative ($8,732,000), the precision medicine initiative ($2,392,000), and the Orphan Product Development Grants Program ($2,500,000). The NIH will receive an extra $2 billion for FY2016, which supported projects specially for Alzheimer’s diseases research, brain research, antibiotic resistance, the Precision Medicine Initiative, etc. Given last week’s report on the phantom menace CRE and growing cases of multi-drug resistant organisms, it’s extremely important antibiotic resistance be given more attention.

Stories You May Have Missed:

  • CDC Establishing Flu Vaccine Efficacy Lab Network – The CDC has provided funding for a network of US institutions to collect and analyze information related to annual flu vaccine effectiveness. “Participating institutions will coordinate enrollment of patients with acute respiratory illness, confirm influenza infection using a standardized reverse-transcription PCR (RT-PCR) assay, and estimate vaccine effectiveness.” The 30 million dollar funded project will run from July 2016-2021.
  • Avian Influenza in France – France has reported 30 outbreaks of avian influenza, specifically one of the highly pathogenic influenza. Unfortunately the strain in the most recent cases hasn’t been identified, but these outbreaks been attributed to one of the H5 strains.
  • Hawaiian Dengue Outbreak Update – Cases of dengue virus on Hawaii Island have now reached 157. There are 7 individuals considered still infectious and the Hawaii Department of Health (HDOH) continues their efforts to identify cases and reduce transmission. 140 of the cases are Hawaii Island residents, and 34 of the overall cases have been children under the age of 18.

Enjoying your weekly dose of the Pandora Report? Sign up to receive it every week so the fun never ends! 

Pandora Report 12.4.2015

This week, Washington, DC hosted the Summit on Human Gene Editing, where the ethical and legal implications of gene editing technologies, like CRISPR-Cas9, were heavily discussed. In this week’s report, Greg Mercer works his magic, revealing the internet and social media trends following the shootdown of a Russian SU-24 on November 24th. We’re also reporting updates in the Zika virus and dengue fever outbreaks as well as the Harvard-LSHTM Panel Report on Global Response to Ebola. France is currently experiencing an increase of highly pathogenic avian influenza cases while a Black Angus beef cow in Alberta was discovered to have bovine spongiform encephalopathy (BSE). Fun history fact Friday – on December 3, 1967, the first human heart transplant was performed in Cape Town, South Africa and on December 4, 1945, the Senate approved US participation in the UN. Before we start our weekly roundup, make sure to mark your calendars to attend GMU’s seminar on Ebola surveillance and laboratory response this Monday, December 7th from 4:30-6pm at our Fairfax campus (details below!).

Zika Virus Outbreak – Updates
The growing outbreak of Zika virus has now seen locally acquired cases reach ten countries, causing the Pan American Health Organization (PAHO) to issue an alert, “urging countries in the region to be on the lookout for the disease and to watch for unusual patterns in newborn.” Brazil has been hit hard with a rise from 739 on November 27th, to 1,248 cases reported on November 30th. Six of the ten countries saw cases occur in November, hinting that the outbreak could just be starting. The growing concerns regarding the outbreak are also related to the newest evidence linking microcephaly and maternal cases. Zika virus genome was found in the amniotic fluid of two pregnant women and fetal diagnosis of microcephaly was performed via ultrasound. Even more so, French Polynesian health officials reported an unusual spike in nervous system malformations in babies that were born during a Zika virus outbreak in the region from 2014 to 2015. The concern regarding neurological conditions raises red flags as Brazilian health officials are reporting neurological complications, like that of Guillain-Barre syndrome, in Zika virus patients. The WHO reported 739 Brazilian microcephaly cases in newborns and while there is only ecological evidence linking the virus and microcephaly, investigations are ongoing. The outbreak first started in February 2014, on Easter Island (Chile) and has seen been identified in Colombia, Guatemala, Brazil, El Salvador, Mexico, Paraguay, Panama (confirmed cases as of December 4, 2015), Suriname, and Venezuela. Spread by Aedes mosquitoes, this vector-borne organism has similar symptoms to dengue fever and illness tends to last between four and seven days.

Event: Ebola Surveillance & Laboratory Response – Lessons for Global Health SecurityScreen Shot 2015-12-03 at 9.34.57 AM
Time/Location: Monday, December 7, 2015 from 4:30pm-6pm in Robinson A-203 at George Mason University.
As the recently released Harvard-London School of Hygiene and Tropical Medicine Independent panel on the Global Response to Ebola indicates, the West African Ebola epidemic highlighted
many gaps in national and international health and response systems that are critical for protecting global health security.  Join leaders and experts who helped to lead the U.S. response for Ebola to discuss the international response to the epidemic, the importance of robust biosurveillance systems, and how the experience with Ebola influences our approach to Global Health Security. Speakers:

  • Dr. Matthew Lim, Senior Policy Advisor for Global Health Security, HHS, fmr Civil-Military Liaison Officer to WHO
  • May Chu, Ph.D. fmr Assistant Director for Public Health, Office of Science Technology and Policy, White House; Senior Science Advisor, CDC
  • Jeanette Coffin, Manager U.S. mobile laboratory deployment, MRIGlobal

It’s Definitely Maybe World War 3
GMU’s Greg Mercer breaks down the November 24th Turkish shootdown of a Russian SU-24. Greg reviews the media attention following the event and the “immediate buzz about declarations of war, what exactly NATO owes Turkey vis-à-vis Russia, and the possibility of military confrontation between Russia and the West.” Through his use of google trends and Twitter, Greg shows just how much hype and concern the notion of WWIII got during this time. Take a look at his recap and debunking of the WWIII buzz and how quickly it caught like wild fire.

Reporting from the Panel on the Final Report of the Harvard-LSHTM Independent Review of the Global Response to Ebola
If you missed the Center for Strategic & International Studies (CSIS) Global Health Policy Center’s Launch of the final report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola, don’t worry! I was fortunate to attend and a great deal of the report (we reported on last week) heavily emphasized “on the ground” capacity. Dr. Peter Piot, Director and Handa Professor of Global Health, London School of Hygiene and Tropical Medicine (LSHTM), joined via video link and started by saying that this would not be a WHO-bashing event. As one of the original researchers on Ebola during its 1976 discovery, he mentioned that the Democratic Republic of Congo (DRC) is a great example of local capacity in their success of ridding themselves of the disease within a few months of the outbreak starting. Dr. Piot heavily emphasized the work of several countries and how the WHO brought together multiple ethicists to review research during such a terrible outbreak. Lastly, Dr. Piot noted that “we risk focussing too much on global and not enough on local” in our future efforts. Dr. Suerie Moon, Research Director and Co-Chair of the Forum on Global Governance for Health at Harvard Global Health Institute, then spoke on the “weak coordination of global response” and how it severely aided the spread of Ebola. Dr. Moon highlighted the need for a global strategy to ensure adequate funding (external financing for the poorer countries and transparent tracking of financing) and the necessity for external assessment of country capacity. She pointed to the need for political and economic incentives and disincentives to not only report cases but also discourage the hiding of outbreaks. Reviewing each recommendation, the panel noted that “human health is a vital part of human security”. In one of her closing comments, Dr. Moon stated that “there are many unanswered questions regarding ebola response and we need to address a number of aspects that went wrong” and “a major theme is accountability at all levels, across all types of players.” Dr. Moon pointed out that the necessity of so many reforms shows just how much work is needed and that now is the time to see political support occur. Muhammad Pate, former Nigerian Minister of State for Health, expressed that “one of the lessons, at the national level, in terms of surveillance and accountability to respond, was missing and something that national leaders need to own up to is building their own public health systems.” Dr. Sophie Delaunay, Doctors Without Borders/MSF, then discussed the role of medical innovations and how the outbreak provided us with a unique opportunity to collect data. Dr. Delaunay said it will “be a complete nightmare to connect all the dots” in this outbreak and there is a desperate need for better R&D regarding disease outbreaks and response. “We ask for governments and policy makers to support collaboration on R&D to demonstrate their willingness to be more effective in the next outbreak” noted Dr. Delaunay. She heavily pushed for global financing efforts to facilitate investment in R&D and response. After the initial panel, there was a secondary group that shared their thoughts on the report, including Dr. Tom Frieden (CDC Director), Julie Gerberding (Exec. VP for Strategic Communications, Global Public Policy and Population Health, Merck) and Ron Klain (Former US Ebola Response Coordinator, White House and General Counsel, Revolution LLC). Ron Klain pointed to the failure of the WHO and “if institutions failed us, individuals shined. We did see extraordinary compassion from the rest of the world and tremendous outpouring of support. ” Mr. Klain mentioned that “the scariest thing about Ebola is the warning signs of how badly we failed this when the threat could’ve been worse and the epidemic we face could be much much more dangerous in the future.” Dr. Frieden emphasized the need of human resources management improvement at the WHO and how global outbreak response could work to support each other better. Lastly, Dr. Frieden emphasized a topic near and dear to my heart; infection control and it’s necessity in global disease prevention. Overall, the panel touched on several key points to the outbreak, emphasizing the need for the biggest players (including MSF) to lead by example via data sharing, etc. The push for political support on incentives and local capacity/accountability was perhaps one of the biggest recommendations and points emphasized from this event.

Gene Editing and CRISPR!
This was a busy week in the biotech world. The International Gene Editing Summit kicked off in Washington, DC. Bringing together experts from around the world, the summit touched on the newest technical innovations, ethical and legal concerns, and even social implications of genome editing advances. Genome Web has provided a great overview of the summit. Nature also published their Four Big Questions related to genome editing, touching on points related to editing the human germline and the ethical implications for technology that “researchers are still grappling with the known unknowns”. Recently, biologist, Emmanuelle Charpentier, discussed CRISPR-Cas9 and that it’s simply too early to begin gene editing as “the tools are not ready” and “as of today, I’m in favor of not having the manipulation of the human germlines. As long as they’re not perfect and ready, I think it’s good to have this ban against editing the germline.” Buzzfeed noted that over the course of the conference, there was a substantial push for a delay in the use of genetic engineering in fertility clinics due to the risk of making “designer babies”. Given the heavily debated nature of this topic it’s not surprising that the US National Academy of Sciences, Engineering and Medicine, the UK’s Royal Society, and the Chinese Academy of Science, all agreed that it “would be irresponsible to proceed with any clinical use of germline editing.” While the future is left open to gene editing on humans, there was heavy accentuation throughout the conference on the ethics and societal views of these scientific breakthroughs and the necessity to revisit their applications on a regular basis.

Dengue Fever Outbreak in Hawaii 
The Dengue fever outbreak on Hawaii Island is still growing. Now at 122 confirmed cases, this is one of the biggest outbreaks they’ve seen with local transmission. As of 12/2, the confirmed cases involved 106 Hawaii Island residents and 16 visitors. The Hawaii Department of Health (HDOH) has published information, hoping to aid prevention efforts, regarding the Aedes aegypti and Aedes albopictus mosquitos that are responsible for spreading the disease. There have been 313 reported potential cases and you can even find a map of the case distribution here!

Stories You May Have Missed:

  • 2015/2016 Flu Season- Where Are We?– The CDC 2015/2016 influenza activity showed a bit of a spike during the November 15-21 week. Influenza A (H3) is still the predominant species in laboratory confirmed cases. If you’re looking to keep an eye on seasonal flu, Google Flu Trends may no longer be operational, but you can still keep an eye on Flu Near You or the CDC’s page.
  • MERS-CoV Severity and Incubation Period– The CDC & Emerging Infectious Diseases published a report regarding the association of severe MERS-CoV illness and a shorter incubation period. Analyses of 170 patents in South Korea revealed a longer incubation period associated with a decreased risk for death while “patients who died had a shorter incubation period.” This mirrors the results of a previous study that had similar results with SARS coronavirus.
  • Salmonella Outbreak Associated With Recalled Nut Butters – The CDC is currently investigating 11 illnesses across nine states that may be linked to recalled nut butters. The Salmonella serotype is Paratyphoid B variant L (+) tatrate (+) (previously called Salmonella Java) and has caused illness in California, Colorado, Georgia, Hawaii, Idaho, Illinois, North Carolina, and New Jersey.
  • Taiwan CDC Holds Bioterrorism Drill – Involving 70 participants, the course utilized a subway union station to allow people to simulate first responders and real-life operations. “CDC bioterrorism teams are tasked with the investigation and identification of biological threats and attacks. Members take on containment and mitigation of damage for any individuals that are harmed during and as a result of an attack.” Go Taiwan!

Enjoying your weekly dose of the Pandora Report? Sign up to receive it every week so the fun never ends! 

Pandora Report: 11.13.2015

Given the auspicious nature of Friday, the 13th, how about we start the Easy-Bake Oven version of bioreactors? (insert evil genius laugh). Our report this week is rich in biosafety, GMU Open Houses, and updates on global outbreaks. Fun History Fact Friday – this week in 1989, the Berlin Wall came down! Before we venture down the rabbit hole, don’t forget to get your flu shot before the 2015/2016 influenza season hits too hard!

DIY Bioengineering 
If you’re in search of the perfect holiday gift for your favorite biodefense/bioengineer, you can thank the creators of Amino (personally, I think calling it the Easy-Bake Oven Bioreactor is just so much more fun). The kit starts at $700 and comes with all the essentials for your “recipe” (main bacterial culture, DNA, pipettes, incubators, agar plates and various sensors for monitoring microbial growth). Did I mention it comes in a nice color-coded, pleasing-to-the-eye plywood dashboard? MIT graduate, Julie Legault, is the master genius behind Amino, and uses the “apps” (step-by-step guides) to help make even the most science adverse individual capable of making DNA products. Liz Stinson points out that “they walk users through how to insert the DNA into untransformed bacteria cells, and how to incubate, grow, and maintain the altered microorganisms”. Just make sure your new gift comes with some information on dual-use research of concern and avoids any select agents…

Master’s Open House 
Make sure to swing by our GMU Master’s Open House on Wednesday, November 18th at 6:30pm to learn about all our different programs! Good news – you can virtually attend via this link and even ask questions live! We’ll be talking biodefense and all the ways you can use our MS degree (online or in person!). Whether its fighting food safety issues, pandemic influenza, or zombies, we’re passionately trying to make the world of global health security stronger and more diverse!

Biological Research: Rethink Biosafety 
“Biology must move forward on safety and security. Let’s not reinvent the wheel, but learn from those doing safety better.” Tim Trevan’s comments echo the sentiments of many within the biosecurity field. The anthrax mishaps at Dugway and the CDC BSL-3 lab in Atlanta compound a growing concern over the handling of select agents and the lab safety practices and processes that seem to be failing. Trevan poses the question, “what are the prospects for managing the more intractable risks globally if measures to ensure the safe handling of dangerous pathogens are failing at the best-equipped facilities in the country with the most advanced biotechnology in the world?” In his words, Trevan has hit the nail on the head and summarized the realities of lab safety culture. So what’s to be done? Trevan makes the unexpected recommendation of  using nuclear security experts to advise on biosafety and biosecurity. This strategy utilizes a practice that is also common in healthcare – a culture of safety. By focussing on the prevention of failure, instead of maximizing output, safety becomes an engrained practice in all levels of an organization, transforming it into a “high-reliability organization” (HRO). By using examples within industries like offshore oil drilling, airlines, etc., Trevan points to the growing biotech capabilities that make biosecurity that much more imperative. In healthcare, I’ve seen organizations truly transform their practices by moving to a culture of safety (and utilizing “just culture” when it comes to patient safety) and while it’s not a wholly easy process, the foundations are already present in the existing teachings of patient care. Labs have the training and knowledge for safety, but as Trevan points out, it’s time to bring in those with the expertise to help move towards a culture of safety.

Screen Shot 2015-11-12 at 9.56.04 AM
Courtesy of HDOH

Dengue Fever Outbreak in Hawaii 
If you’re considering a winter retreat to Hawaii, make sure to grab some bug spray. Hawaii Island is currently experiencing a Dengue outbreak that has just reached 33 cases. Dengue is not endemic to Hawaii and while travelers have imported cases from time to time, this is marks the first big cluster of locally-acquired cases since 2011. The Hawaii Department of Health (HDOH) continues investigations and reports (as of 11/11)  25 Hawaii Island residents and 8 visitors have been laboratory confirmed with dengue fever. The HDOH has provided maps related to exposure areas to help people avoid high-risk locations or at least use preventative measures. If you’re traveling to Hawaii Island or an area where dengue is endemic, make sure to take steps to reduce the risk of mosquito bites and the potential for transmission!

Ebola Update
Guinea has reported no new cases in the last week. While they’re still on high alert after the cases surrounding a family, they are hopeful. Liberia and Sierra Leone have hit their 90-day enhanced surveillance period, meaning they have no new cases and are now working towards the WHO’s second objective (managing and responding to residual risks). Pauline Cafferkey has made a full recovery after her hospitalizations due to post-Ebola recovery complications. Researchers at Columbia University’s Mailman School of Public Health used a new statistical model to map the outbreak. Results will be published in the Journal of Royal Society Interface, which shows the development of the outbreak and role early detection and response plays.

Stories You May Have Missed: 

  • Joint Services Mask Leakage Tester (JSMLT) Contract – the DoD has announced that Air Techniques International, Inc. has been awarded a contract regarding the maintenance of the JSMLT. The JSMLT does quality control and ensures proper fitting (portably) on CBRN protective masks.
  • H7N9 Cases in China Rise– China has confirmed two more cases that occurred in October, bringing the total case count to four. Many in public health are noting that these cases bring about a fourth wave of infections (starting in October). The two new cases were a a 62-year-old woman from Shengzhou and a 51-year-old farmer from Hangzhou.
  • Boosting Biosecurity in Nigeria & Kenya– The Institute of Human Virology at the University of Maryland have announced two grants to help build biosecurity in Nigeria and Kenya. The first grant of $13 million will go to strengthen laboratory infrastructure in Kenya, and the second of $10 million will help those in Nigeria quickly detect and respond to emerging infectious diseases.

Enjoying your weekly dose of the Pandora Report? Sign up to receive it every week so the fun never ends! 

Pandora Report 8.16.15

It looks like the blog isn’t the only place with a lull during the summer. This week was oddly slow for news; maybe it’s an August thing? For our top stories we’ve got ISIS with chemical weapons and, from our neighbor to the north, a disease diagnosing fabric. We’ve even got a few stories you may have missed.

Have a great week!

U.S. Investigating ‘Credible’ Reports that ISIS Used Chemical Weapons

The U.S. is investigating what it believes are credible reports that ISIS fighters used mustard agent against Kurdish Peshmerga fighters in Makhmour in Northern Iraq. ISIS posted about the attack on social media, but American officials have stated they have independent information that left them believing that a chemical weapon was used. A German Ministry of Defense spokesman echoed that they cannot confirm or rule out that a chemical weapons attack occurred. The major question for U.S. officials is to determine if it was mustard gas, and if so, how ISIS came to possess it.

CNN—“Blake Narenda, a spokesperson for the State Department’s Arms Control, Verification and Compliance Bureau, said, “We continue to take these and all allegations of chemical weapons use very seriously. As in previous instances of alleged ISIL use of chemicals as weapons, we are aware of the reports and are seeking additional information. We continue to monitor these reports closely, and would further stress that use of any chemicals or biological material as a weapon is completely inconsistent with international standards and norms regarding such capabilities.”

CNN has previously reported claims from monitoring groups that ISIS used chlorine weapons against Kurdish forces.”

Halifax Scientist Develops High-Tech Fabric that Helps Diagnose Diseases

Yes, you read that right. Christa Brosseau, an analytical chemist at Saint Mary’s University in Halifax, Nova Scotia, is working on the development of a chemical sensor which can be built into fabric and can detect diseases like tuberculosis, malaria, and HIV/AIDS.  How is this even possible? First the scientists make Nanoparticles, then aggregate those particles which ends up as a silver Nanoparticle paste. That paste can be placed on a fabric chip and it then ready to use. The fabric chip interacts with bodily fluids like sweat, saliva, or urine, and is then scanned for information.

CTV—“The technology picks up disease biomarkers and the scientists are able to get results in approximately 30 seconds, by using hand held units, the size of a TV remote control, to scan the samples. The size of the units makes them convenient for working in the field.

Eventually, the scientists hope to see the technology deployed in exercise headbands, or cloth inserts in infant diapers, to better monitor the state of health.”

Stories You May Have Missed

Image Credit: U.S. Army

Pandora Report 4.19.15

Sunday has to be the biggest brunch day of the week, so it is only fitting that our lead story looks at the many (delicious and nutritious) uses of maple syrup. We also look at Dengue fever in Brazil, missteps in the U.S. fight against Ebola, and other stories you may have missed.

Once you’re updated, get out there and enjoy the rest of your weekend and the beautiful weather! Have a great week!

Syrup Extract Found to Make Antibiotics More Effective Against Bacteria

It seems like we look at growing antibiotic resistance every week here at Pandora Report. This week, researchers at McGill University in Montreal reported that a “concentrated extract of maple syrup makes disease-causing bacteria more susceptible to antibiotics.” This finding suggests that combining the extract with antibiotics could increase their effectiveness and lead to lower antibiotic usage overall. Honestly, is there anything maple syrup can’t make better?!

Infection Control Today—“‘We would have to do in vivo tests, and eventually clinical trials, before we can say what the effect would be in humans,” [Professor Nathalie] Tufenkji says. “But the findings suggest a potentially simple and effective approach for reducing antibiotic usage. I could see maple syrup extract being incorporated eventually, for example, into the capsules of antibiotics.’”

Brazilian Teams on Alert because of Dengue Fever Outbreak

Brazilian soccer teams are on high alert because of a dengue fever outbreak that has already affected some of the country’s top teams. This week three players were diagnosed with the mosquito borne disease, which normally takes about two weeks to recover from. Players have been forced to use insect repellent during games and practices and health officials have been asked to check fields and training centers for mosquito breeding sites.

USA Today—“Cases of dengue fever have increased significantly across Brazil this year, with most of them reported in Sao Paulo state. Brazil’s health ministry said there have been more than 460,000 cases of the disease in the country in 2015, which accounts for almost 5,000 cases a day. More than 130 people have died so far this year, the ministry said.”

Empty Ebola Clinics in Liberia Are Seen as A Misstep in U.S. Relief Effort

After spending hundreds of millions of dollars and deploying 3,000 U.S. troops to build Ebola treatment centers (E.T.C.) in Liberia, the facilities have largely sat empty. Only 28 Ebola patients have been treated at the 11 E.T.C.s built by the U.S. military. Nine of the centers never had a single Ebola patient. Looking back, the emphasis on building E.T.C.s had far less of an impact than the “inexpensive, nimble measures taken by residents to halt the outbreak.”

The New York Times—“Had the Americans and other donors been more flexible, critics and some officials contend, the money could have been put toward rebuilding Liberia’s shattered health care system—or backing the efforts of local communities—instead of focusing on treatment centers that would scarcely be used.”

Stories You May Have Missed

 

Image Credit: Dvortygirl

Pandora Report 12.21.14

The winter holidays are here and with them comes the final 2014 news roundup. This week we look at superspreaders, dengue fever, and, of course, Ebola.

There will be no roundup next week as I will be spending time with family and friends. I hope all of you have the opportunity to do the same and are surrounded by those you love during this time of year. It has been a privilege and a pleasure serving as the Managing Editor of the Pandora Report since March. I hope you have enjoyed reading it as much as I’ve enjoyed writing it.

I hope to see you right back here again in 2015!

The 20% Who Spread Most Disease

How did Typhoid Mary spread the disease to dozens of people but never get sick herself?

Researchers at Stanford University are looking into the science behind “superspreaders”—the idea that some people spread more disease than others. Recent experiments have suggested that the body’s immune response might play a role in helping to spread pathogens to others, however, it isn’t clear if the immune system of the superspreader or their behavior plays a bigger role in the passage of disease.

The Wall Street Journal—“‘It’s telling us that these superspreaders…are tolerant of high levels of the pathogen and any little disturbance and added inflammation that this antibiotic treatment did to them,” said Dr. Monack. “I wouldn’t say they have stronger immune systems. I would say it’s in a state that protected them from this added disturbance in the gut.’”

Dengue Fever Vaccine on the Cards After Novel Antibody Discovery

Over the past 50 years cases of dengue fever have soared—nearly 100 million per year. Normally the infection causes a fever which lasts about a week, but some develop hemorrhagic fever which kills about 22,000 a year. Gavin Screaton at the Imperial College in London warns “it’s likely that without a vaccine this disease is not going to be controlled.” That’s why a discovery of a new antibody brings hope that vaccine development may be closer than we thought.

The Guardian—“The researchers spotted the new group of antibodies while they were studying blood drawn from patients who picked up dengue infections in south-east Asia.

They found that about a third of the immune reaction launched by each patient came from a new class of antibodies. Instead of latching on to a single protein on the virus surface – as usually happens – the new group of antibodies latches on to a molecular bridge that joins two virus proteins together.”

This Week in Ebola

It’s been a hard year in West Africa with the worst Ebola outbreak in history still ongoing. In Sierra Leone, the country with the most cases, treatment centers are overflowing with patients. The President has announced that Christmas has been cancelled as news came that the most senior doctor—Victor Willoughby—died. Dr. Willoughby was the 11th of Sierra Leone’s 120 doctors to die from the virus. For the lucky ones who survive, they must cope with after effects including blindness and joint pain. And don’t forget the stigma—a heart breaking article in the New York Times describes the plight of Ebola orphans who aren’t taken in for fear that they are ticking disease time bombs. Cuban doctors are some of the most active on the front lines, but news this week came that the U.S. embargo has delayed payment of those doctors. There are glimmers of hope though, as the U.N. Economic Commission for Africa urged debt cancellation for Ebola affected West African countries and experimental serum therapy treatment made from the blood of recovered patients arrived in Liberia.

Stateside, a child flying though O’Hare Airport in Chicago was quarantined when a high fever was discovered after screening. Johns Hopkins University was chosen as one of the winners in a global competition to create an improved protection suit for those fighting Ebola on the front lines. Lastly, an American doctor—Richard Sacra—who was infected with Ebola in Liberia and returned to the U.S. for treatment, has said that he will return to Liberia in January to continue fighting the outbreak.

Stories You May Have Missed

 

Image Credit: Free Images

Pandora Report 9.20.14

We are introducing a new feature for the news round up—“Stories You May Have Missed.” This final section consists of fascinating articles I’ve found throughout the week that couldn’t fit in the report. This week the round up includes the UN Security Council’s resolution about Ebola, ISIS using chemical weapons in Iraq, a surprising source to combat antibiotic resistance, and of course, an Ebola update.

Lastly, you know what time of year it is, flu season is starting…don’t forget to get your flu shot!

Have a great weekend!

With Spread of Ebola Outpacing Response, Security Council Adopts Resolution 2177

On Thursday, the United Nations Security Council met to discuss the Ebola outbreak in West Africa and unanimously adopted resolution 2177 (2014). 2177 established the United Nations Mission for Ebola Emergency Response (UNMEER) and calls on Liberia, Sierra Leone, and Guinea to speed up establishment of national mechanisms to deal with this outbreak and to coordinate efficient utilization of international assistance, including health workers and relief supplies. The resolution also calls on other countries to lift their border and travel restrictions saying that isolation of the affected countries could undermine efforts to respond to the outbreak.

The United Nations—“United Nations Secretary-General Ban Ki-Moon said that the Ebola crisis had evolved into a complex emergency, with significant political, social, economic, humanitarian and security dimensions.  The number of cases was doubling every three weeks, and the suffering and spillover effects in the region and beyond demanded the attention of the entire world.  “Ebola matters to us all,” he said.”

ISIS Uses Chemical Weapons Against Army in Iraq

There were reports this week that the IS terrorist group has used chemical weapons in an attack on the Iraqi army in Saladin province. The reported attack took place Wednesday and Thursday in Dhuluiya, which has been under control of the group for more than two months. The attack affected approximately a dozen people.

One India—“Iraq’s Ambassador to the UN, Mohamed Ali Alhakim said in a letter that remnants of 2,500 chemical rockets filled with the deadly nerve agent sarin were kept along with other chemical warfare agents in a facility 55 km northwest of Baghdad. He added that the site’s surveillance system showed that some equipment had been looted after “armed terrorist groups” penetrated the site June 11.”

Vaginas May be the Answer to the Fight Against Drug-Resistant Bacteria

A naturally occurring bacterium found by scientists from the University of California, San Francisco, School of Pharmacy might be the key to addressing the threat of a post antibiotic future. Found in the female vagina, Lactobacillus gasseri is the basis for Lactocilin, a possible antibiotic alternative. This discovery comes at a time where the WHO has declared antimicrobial resistance as “an increasingly serious threat to global public health.”

Medical Daily—“This isn’t the only implication for the L. gasseri bacteria. Researchers are also hopeful to find similar-acting bacteria in different parts of the human body. “We think they still have bacteria producing the same drug, but it’s just a different bacterial species that lives in the mouth and has not yet been isolated,” lead researcher Micheal Fischbach told HuffPost. Even though the bacteria were harvested in females, researchers are confident it will have equal results when used in men.”

This Week in Ebola

It was a terrible week for Ebola, absolutely terrible. Above, we already learned that the UN Security Council declared the virus a threat to international peace and security, but that wasn’t all that happened. President Obama pledged 3,000 troops to fight Ebola in West Africa. The WHO said that the number of Ebola cases could begin doubling every three weeks and expressed concern about the black market trade of Ebola survivors’ blood. Eight aid workers and journalists were murdered in Guinea leaving many to fear that violence could stymy relief efforts and in Sierra Leone, the government instituted a three-day lockdown in order to help health care workers find and isolate patients.

Stories You May Have Missed

 

Image Credit: Wikimedia

Pandora Report 9.6.14

This week we cover dengue in Japan, dog flu in NYC, more forgotten lethal specimens in government labs, and of course, an Ebola update.

Canine Influenza Cases Spreading in Manhattan

Flu season is rapidly approaching, and evidently, it doesn’t only affect humans. Veterinarians in Manhattan have reported cases throughout the borough. The cases are likely due to dogs playing with other infected dogs at parks and dog runs. Vets warn owners to watch for coughing dogs and if they are present to take their dog to another area. The good news is, just like their human counterparts, dogs, too, can receive a flu vaccine.

The Gothamist—“According to the ASPCA, symptoms include coughing, sneezing, difficulty breathing, fever, lethargy and loss of appetite; most dogs will recover within a month, but secondary infections like pneumonia can be problematic.”

 

New Cases of Dengue Fever Should be a Wake-Up Call for Japan

As many as 70 people in Japan have been infected with Dengue fever—traditionally, a disease found in tropical climates—the country’s first outbreak since 1945. The diagnoses prompted authorities to fumigate an area of Yoyogi Park in Tokyo’s Shibuya Ward, which was the apparent source of the infections. Dengue fever is transmitted by mosquitos and produces an extremely high fever and pain in the joints. The disease is not transmitted person to person.

The Asahi Shimbun—“The most effective way to deal with a global dengue epidemic is to step up the efforts to exterminate mosquitoes in countries with a large number of patients, especially in urban areas.”

 

Forgotten Vials of Ricin, Plague, and Botulism found in U.S. Government Lab 

A strong feeling of deja vu hit this week when we learned about yet another case of forgotten vials of dangerous pathogens at U.S. labs. In this case, the containers were discovered during an investigation of NIH facilities after scientists found vials of smallpox earlier this summer. This search discovered a century (!!) old bottle of ricin, as well as samples of tularemia and meliodosis. The FDA also reported they found an improperly stored sample of staphylococcus enterotoxin.

The Independent—“The NIH does have laboratories that are cleared to use select agents, and those pathogens are regularly inventoried, the director of research services Dr. Alfred Johnson said. However, these samples were allowed to be stored without regulation.”

 

This Week in Ebola

We learned that new cases of Ebola in Democratic Republic of Congo are genetically unrelated to the West African strain and that researchers from the Broad Institute and Harvard are working to sequence and analyze virus genomes from the West African outbreak. Senegal is working hard to manage contacts with the Guinean student who tested positive for the virus in the capital, Dakar. Human trials of an Ebola vaccine continued in the U.S. and are planned to take place in Mali, the U.K., and Gambia. A third American infected with Ebola will return to the U.S. and will be treated at a Nebraska medical containment unit which was built for the SARS outbreak. I read an article that hypothesized that Ebola may be able to be transmitted sexually which could account for a high number of cases, while the Washington Post pointed to the fact that the West Africa outbreak is drawing attention from diseases which are more widespread and kill more people—it’s the Kardashian of diseases. Lastly, CDC Director Dr. Thomas Frieden said that this outbreak of Ebola is “threatening the stability” of affected and neighboring countries, and Dr. Daniel Lucey, of the Georgetown University Medical Center, predicts that the current outbreak “will go on for more than a year, and will continue to spread unless a vaccine or other drugs that prevent or treat the disease are developed.”

 

Image Credit: Wikimedia Commons